Reprogramming of a human induced pluripotent stem cell (iPSC) line from a Parkinson's disease patient with a R1628P variant in the LRRK2 gene
Authors:
Open Access
- 1 January 2017
- journal article
- Published by Elsevier in Stem Cell Research
- Vol. 18, 45-47
Abstract
No abstract availableKeywords
Funding Information
- National Medical Research Council
- Translational Clinical Research (NMRC/TCR/013-NNI/2014)
- STaR award (NMRC/STaR/014/2013)
This publication has 4 references indexed in Scilit:
- LRRK2 G2385R and R1628P Mutations Are Associated with an Increased Risk of Parkinson’s Disease in the Malaysian PopulationBioMed Research International, 2014
- Human Finger-Prick Induced Pluripotent Stem Cells Facilitate the Development of Stem Cell BankingStem Cells Translational Medicine, 2014
- Association of LRRK2 exonic variants with susceptibility to Parkinson's disease: a case–control studyThe Lancet Neurology, 2011
- Efficient generation of transgene-free human induced pluripotent stem cells (iPSCs) by temperature-sensitive Sendai virus vectorsProceedings of the National Academy of Sciences, 2011